GSK plc vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
GSK
High-quality business with 41% return on equity and 18% profit margins.
⚠ cautious analyst consensus — few Buy ratings.
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $57.65 (+11.7%)
8 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
GSK
UNH
13.4×
Trailing P/E
27.9×
9.9×
Forward P/E
17.8×
17.8%
Profit Margin
2.7%
72.9%
Gross Margin
18.8%
40.9%
ROE
12.2%
1.5%
Revenue Growth
2.0%
8.4%
Earnings Growth
0.7%
0.35
Beta
0.41
—
Price / Book
—
$103.0B
Market Cap
$334.9B
$35 – $62
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →